Endocrinology, Diabetes & Metabolism Doctors in St Petersburg, FL Accepting Medicare

4 Endocrinology, Diabetes & Metabolism doctors found. Showing 1 - 4

Dr. Paul Edward Dimarco, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 603 7th St S, Ste 590, St Petersburg, FL 33701 Phone: 727-441-4581    Fax: 727-443-2307

Richard F. Blanchard, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 620 10th Street N., St Petersburg, FL 33705 Phone: 727-824-8251    Fax: 727-824-8271

Dr. Arvind Rama Parbhoo, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 4820 5th Ave N, St Petersburg, FL 33713 Phone: 727-528-1138    Fax: 727-528-2295

Charyse J Sindler, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 620 10th St N Ste 3e, St Petersburg, FL 33705 Phone: 727-824-8251    Fax: 727-824-8271

News Archive

Researchers discover enzyme that is a natural tumor suppressor

Building on their 2005 discovery of an enzyme that is a natural tumor suppressor, researchers at the University of California, San Diego (UCSD) School of Medicine have now identified two variants of that enzyme which could provide new targets for therapies to treat diabetes, heart and neurological disease.

Global Fund board members discuss new funding allocation model amid some concerns from TB advocates

The board of the Global Fund to Fight AIDS, Tuberculosis and Malaria began a two-day meeting in Geneva on Thursday, "with one topic high on the agenda: a new funding model," Devex's "Development Newswire" reports.

FDA clears NEC's MultiSync MD215MG medical diagnostic monitor

NEC Display Solutions of America, a leading provider of commercial LCD display and projector solutions, announced today the Food & Drug Administration 510(k) market clearance of the 21.3-inch MultiSync MD215MG medical diagnostic display for the displaying and viewing of digital mammography images for diagnosis by trained physicians.

Targacept, AstraZeneca expand TC-5619 development program to include ADHD, Alzheimer's disease

Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced an amendment to its 2005 collaboration agreement with AstraZeneca expanding the TC-5619 development program. In addition to the current development of TC-5619 in cognitive dysfunction in schizophrenia (CDS), the amended terms provide for parallel development in attention deficit/hyperactivity disorder (ADHD) and potentially Alzheimer's disease.

Medical device set to go a Storm worldwide

Intelligent Orthopaedics, an innovative orthopaedics device company backed by Staffordshire University, has entered into a long-term global distribution agreement with BSN medical, a world leading medical device company.

Read more Medical News

› Verified 2 days ago